TP53 and neoplasm: Continuous, long-term statin treatment of an R270H orthotopic lung tumor model significantly reduced tumor burden and improved host survival, demonstrating the therapeutic potential of this statin on lung tumors harboring this particular p53 mutation (Fig. 7E,F).